EE47 Cost-Effectiveness of Abiraterone, Enzalutamide, and Apalutamide in Metastatic Castration-Sensitive Prostate Cancer (MCSPC): A Partitioned-Survival Model

Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.353
https://www.valueinhealthjournal.com/article/S1098-3015(23)00453-9/fulltext
Title : EE47 Cost-Effectiveness of Abiraterone, Enzalutamide, and Apalutamide in Metastatic Castration-Sensitive Prostate Cancer (MCSPC): A Partitioned-Survival Model
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00453-9&doi=10.1016/j.jval.2023.03.353
First page :
Section Title :
Open access? : No
Section Order : 11741
Categories :
Tags :
Regions :
ViH Article Tags :